These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseases. Hombach A; Pohl C; Reinhold U; Abken H Hybridoma; 1999 Feb; 18(1):57-61. PubMed ID: 10211789 [TBL] [Abstract][Full Text] [Related]
8. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes. Shirasu N; Kuroki M Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678 [TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions. Chicaybam L; Sodré AL; Bonamino M Int Rev Immunol; 2011; 30(5-6):294-311. PubMed ID: 22053970 [TBL] [Abstract][Full Text] [Related]
10. CAR T-cell Therapy: A New Era in Cancer Immunotherapy. Miliotou AN; Papadopoulou LC Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553 [TBL] [Abstract][Full Text] [Related]
11. From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells. Eshhar Z Hum Gene Ther; 2014 Sep; 25(9):773-8. PubMed ID: 25244568 [No Abstract] [Full Text] [Related]
13. Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy. Rubin CB; Elenitsas R; Taylor L; Lacey SF; Kulikovskaya I; Gupta M; Melenhorst JJ; Loren A; Frey N; June CH; Porter D; Rosenbach M J Am Acad Dermatol; 2016 Nov; 75(5):1054-1057. PubMed ID: 27745631 [No Abstract] [Full Text] [Related]
14. Chimeric antigen receptor T-cell therapy to target hematologic malignancies. Kenderian SS; Ruella M; Gill S; Kalos M Cancer Res; 2014 Nov; 74(22):6383-9. PubMed ID: 25371415 [TBL] [Abstract][Full Text] [Related]
15. CARTs for Solid Tumors: Feasible or Infeasible? Li W; Song X; Jin Y; Li F; Yu H; Cao C; Jiang Q Oncol Res Treat; 2017; 40(9):540-546. PubMed ID: 28813706 [TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities. Wegner A Immunotherapy; 2017 Jun; 9(8):669-680. PubMed ID: 28653571 [TBL] [Abstract][Full Text] [Related]
17. Chimeric Antigen Receptor T Cell Therapy in Hematology. Ataca P; Arslan Ö Turk J Haematol; 2015 Dec; 32(4):285-94. PubMed ID: 26377367 [TBL] [Abstract][Full Text] [Related]
18. [T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases]. Vdovin AS; Bykova NA; Efimov GA Mol Biol (Mosk); 2017; 51(6):1008-1023. PubMed ID: 29271964 [TBL] [Abstract][Full Text] [Related]
19. Armed T cells with CAR for cancer immunotherapy. Wei YQ Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712 [No Abstract] [Full Text] [Related]
20. Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer. Li F; Zhang T; Cao L; Zhang Y Curr Stem Cell Res Ther; 2018; 13(5):327-335. PubMed ID: 29676233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]